TET2 and myelodysplastic syndrome: Our in vivo model of cohesin-mutant MDS arising in a setting of Tet2-mutant clones recapitulates the sequential acquisition of cohesin mutations in the context of Tet2-mutant clonal hematopoiesis and the phenotype observed in patients.